Creative Commons source reading · Image guidance and surgical robotics
Risk of new endocrinological deficits after intraoperative MRI-guided additional resection in endoscopic non-functioning pituitary adenoma surgery.
Stefanos Voglis; Meltem Gönel; Maria Triantafyllidou; Victor Staartjes; Gianluca Mosca; Jacopo Bellomo; Benjamin Beyersdorf; Kevin Akeret; Bas van Niftrik; Michael Hugelshofer; Bettina Winzeler; Zoran Erlic; Luca Regli; Carlo Serra
Originally published in Pituitary · 2026-07-11
From the article
Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.
Abstract
Objective Intraoperative magnetic resonance imaging (ioMRI) has been increasingly used in transsphenoidal surgery for pituitary adenomas to improve the rate of gross total resection (GTR). However, its influence on postoperative pituitary function-particularly the risk of new endocrinological deficits (EDs) due to an additional resection-has not been investigated in detail. This study aimed to evaluate the endocrinological outcomes of ioMRI-guided TSS in patients with nonfunctioning pituitary adenomas (NFPAs), with a focus on the risk of new EDs following ioMRI-guided additional resection. Methods We performed a retrospective cohort analysis of prospectively collected data from 312 patients who underwent endoscopic transsphenoidal surgery with the "chopsticks" technique between July 2013 and July 2022. Of these, 155 patients met the inclusion criteria: histologically confirmed NFPA phenotype and 3-Tesla ioMRI usage. All patients had at least 3 months of endocrinological and MRI follow-up. Hormonal outcomes were reviewed by a dedicated endocrinologist using clinical and biochemical assessments.
Discussion
The central objective of the present study was to determine whether the pursuit of maximal resection using ioMRI increases the risk of these deficits. Our data demonstrate that the rate of new permanent EDs of at least one axis at final follow-up was 18%, a figure that remains well within the reported literature range of up to 35% [5, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33] (Supplementary Table 7). No correlation was found between patients who showed recovery of pituitary function and additional resection with ioMRI.
Conclusion
In summary, the use of ioMRI during TSS for NFPA facilitates the conversion of a substantial percentage of cases to GTR without an associated increase in the risk of permanent new endocrinological deficits. While the safety of ioMRI-guided additional resection is demonstrated in our cohort, the interpretation of endocrine outcomes across the broader literature remains fundamentally challenged by the lack of standardized reporting. Significant discrepancies in how new deficits and hormonal recovery are defined limit the comparability of multi-institutional data.
Editorial reading guide
- How were patients or cases selected, and what did the authors use as a comparator?
- Which outcomes, complications and follow-up intervals determine how far the findings apply?
